GT Biopharma Inc (GTBP)
3.05
-0.14
(-4.49%)
USD |
NASDAQ |
May 15, 16:00
3.05
0.00 (0.00%)
After-Hours: 16:09
GT Biopharma Cash from Investing (Quarterly): 0.478M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.478M |
| September 30, 2023 | 1.845M |
| June 30, 2023 | 2.657M |
| March 31, 2023 | -6.989M |
| December 31, 2022 | 7.506M |
| September 30, 2022 | 0.025M |
| June 30, 2022 | 1.081M |
| March 31, 2022 | 3.533M |
| December 31, 2021 | 2.991M |
| September 30, 2021 | -26.03M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.20M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | |
| December 31, 2018 | -0.032M |
| September 30, 2018 | -0.002M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.002M |
| December 31, 2017 | -0.004M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | -0.006M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | -0.002M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-26.03M
Minimum
Sep 2021
7.506M
Maximum
Dec 2022
-0.7473M
Average
0.025M
Median
Sep 2022
Cash from Investing (Quarterly) Benchmarks
| Cutera Inc | -0.278M |
| Outlook Therapeutics Inc | -- |
| 180 Life Sciences Corp | -- |
| Journey Medical Corp | 0.00 |
| NovaBay Pharmaceuticals Inc | 1.068M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.047M |
| Free Cash Flow | -8.852M |
| Free Cash Flow Per Share (Quarterly) | -1.426 |
| Free Cash Flow Yield | -213.2% |